4.2.3 Antimanic drugs

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

58 library items in 4.2.3 Antimanic drugs

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

4: Central nervous system (remove) , 4.2 Drugs used in psychoses and related disorders (remove) , 4.2.3 Antimanic drugs (remove)

Sort by: Display summary:

Results 1 - 10 of 58

Result page:
Previous
|
1
2
3
4
5
6
|
Next

1.

US drug company to pay $1.6bn over improper marketing of Depakote®

Source: BBC Health ,
Date published: 09/05/2012

Category:

4.2.3 Antimanic drugs | Law/ medical ethics/ litigation | Mental Health

NeLM Area:

News

Link
2.

Lithium toxicity profile: systematic review and meta-analysis

Source: Lancet,
Date published: 20/01/2012

Category:

4.2.3 Antimanic drugs | Adverse Drug Reactions | Mood disorders (including depression)

NeLM Area:

News

Abstract

Link to Comment
3.

AWMSG issues Final Appraisal Recommendation on the use of sodium valproate (Episenta®) for the treatment of manic episode in bipolar disorder

Source: All Wales Medicines Strategy Group (AWMSG),
Date published: 12/01/2012

Category:

4.2.3 Antimanic drugs | 4.8.1 Control of epilepsy | Mood disorders (including depression)

NeLM Area:

Evidence > Drug Specific Reviews

Recommendation
4.

RCT: Chronic divalproex sodium does not attenuate agitation and clinical progression of Alzheimer disease

Source: Arch Gen Psychiatry,
Date published: 02/08/2011

Category:

4.2.3 Antimanic drugs | Dementia

NeLM Area:

News

Abstract
5.

NICE guideline on bipolar disorder: review consultation

Source: NICE,
Date published: 02/06/2011

Category:

4.2.3 Antimanic drugs | Clinical guidelines | Mood disorders (including depression) | National Institute of Clinical Excellence (NICE)

NeLM Area:

News

Consultation area of NICE website
6.

Valproate vs. lithium in the treatment of bipolar disorder in clinical practice

Source: Br J Psychiatry,
Date published: 19/05/2011

Category:

4.2.3 Antimanic drugs | Mood disorders (including depression)

NeLM Area:

News

Abstract
7.

Bipolar medication use and adherence to antiretroviral therapy among patients with HIV-AIDS and bipolar disorder

Source: Psychiatric Services,
Date published: 02/03/2011

Category:

4.2.3 Antimanic drugs | 5.3.1 HIV infection | Compliance | Mood disorders (including depression)

NeLM Area:

Evidence > Medicines Management > References

Abstract link
8.

Aripiprazole (Abilify®) approved in US for maintenance treatment of bipolar I disorder as an adjunct to either lithium or valproate

Source: BioSpace,
Date published: 18/02/2011

Category:

4.2.3 Antimanic drugs | Food &Drug Administration (FDA) | Licence extension | Mood disorders (including depression)

NeLM Area:

News

Link
9.

Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode

Source: DARE,
Date published: 17/01/2011

Category:

4.2.3 Antimanic drugs | Mood disorders (including depression)

NeLM Area:

Evidence > Drug Specific Reviews

DARE abstract
10.

Clinical review: Bipolar disorder

Source: N Engl J Med,
Date published: 06/01/2011

Category:

4.2.3 Antimanic drugs | 4.3 Antidepressant drugs | Drug reviews | Mood disorders (including depression)

NeLM Area:

News

Link- full text restricted to subscribers

Results 1 - 10 of 58

Result page:
Previous
|
1
2
3
4
5
6
|
Next